Advertisement

Topics

Companies Related to "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" [Most Relevant Company Matches] - Page: 20 RSS

01:26 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" found in our extensive corporate database of over 50,000 company records.

Showing "Antigonadotropin Leuprolide Alzheimer Disease Drug INvestigation ALADDIN Study" Companies 476–500 of 6,100+

Probably Relevant

Bactevo Ltd.

Bactevo has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advance machine learning, TIME utilises its paradigm shift in the speed, efficiency and quality of drug discovery, as well as dramatically enhanced safety profiling, to improve clinical success. In addition to working with partners ...


Perlegen Sciences, Inc.

Perlegen Sciences was formed in late 2000 to accelerate the development of high-resolution, whole genome scanning. Three key factors differentiate Perlegen from other organizations involved in the science of genomics: Our genome scanning focuses exclusively on DNA; not RNA expression, not proteins, not enzymes, not metabolism. Just DNA. Period. The beauty of DNA is that it is finite. It is effecti...

karo bio

KARO BIO IS AN ESTABLISHED GLOBAL LEADER IN THE FIELD OF NUCLEAR RECEPTOR RESEARCH AND DRUG DISCOVERY.Karo Bio is committed to finding new and better pharmaceuticals that can effectively treat serious diseases without the deleterious side effects commonly experienced with today's drugs.Karo Bio is a drug discovery company focusing its research on the discovery and pre-clinical phases of drug devel...


Nuix

Nuix (www.nuix.com) enables people to make fact-based decisions from unstructured data. The patented Nuix Engine makes small work of large and complex human-generated data sets. Organizations around the world turn to Nuix software when they need fast, accurate answers for digital investigation, cybersecurity, eDiscovery, information governance, email ...

Oy Jurilab Ltd.

Jurilab is dedicated to applying its proprietary discoveries of genes and genetic markers associated with the route cause of common diseases and drug response across healthcare.Combining access to the unique East Finland founder population with state-of-the-art technologies, the company has gone far beyond initial gene discovery and biochemical services to providing genetic markers for mainstream ...

Openly Rare with Paul Kidwell

Openly Rare with Paul Kidwell is a monthly podcast covering all aspects of rare diseases and will feature conversations with newsmakers and leaders from the world of biomedical and academic research, patient engagement, caregiving, rare disease patients and their families, as well as others who in some way have been touched by the growing number of rare il...

MicroDose Technologies, Inc.

MicroDose Technologies, Inc. is a privately held premier drug delivery and specialty pharmaceuticals company. Founded in 1998, MicroDose is pioneering the use of proprietary drug delivery platforms for the pulmonary, oral and transdermal delivery of medications for improved efficacy and compliance. MicroDose's current focus is on the chronic disease states such as asthma, COPD, diabetes, hypertens...

Tanabe Research Laboratories U.S.A., Inc

Tanabe Research Laboratories U.S.A., Inc. (TRL), is a wholly owned subsidiary of Tanabe Seiyaku Co., Ltd., headquartered in Osaka, Japan. TRL has a research group of approximately 32 employees which includes a current total of 16 PhD’s. The staff is highly skilled in biology and/or chemistry and at working in a collaborative environment to discover, optimize and develop pharmaceutical products. ...

Advanced Biomedical Research, Inc

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in the heart of New Jersey's pharmaceutical R&D corridor in Princeton, NJ. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and clinical data ...

Sunrise Senior Living, LLC

Sunrise Senior Living, a McLean, Va.-based company, employs approximately 29,000 people. As of April 1, 2014, Sunrise operated 290 communities in the United States, Canada and the United Kingdom, with a unit capacity of approximately 26,400 units. Sunrise offers a full range of personalized senior living services, including independent living, assisted liv...

BioStratum Incorporated

BioStratum is focused on the discovery, development and commercialization of novel therapeutic agents for the treatment of diabetes and diabetic complications. BioStratum's pipeline is led by Pyridorin™ a small molecule drug for the treatment of diabetic kidney disease, followed by pre-clinical compounds that will treat other diabetic complications and cancer. Pyridorin has been granted Fast Tra...

Proteome Factory AG

The Proteome Factory AG is a modern biotech company specialized in proteomics, protein analysis, target validation and bioinformatics. The proteomic key technology platform significantly increases the chances to identify new drug targets in emerging disease and biomarkers of disease state. Additionally, the finding of biomarkers significantly enhances the opportunities for individual disease treat...

TP Therapeutics, Inc.

TP Therapeutics, Inc. (TP) is a clinical-stage structure-based drug design company founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drug crizotinib. TP Team is focusing on the design and development of novel chemical identities for established oncogene drivers with high incidence of secondary resistant mutations, ...

Novogen

Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disease) Osteoporosis Rheumatoid arthritis Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease) Neurological diseases (Parkinson's Disease, motor neurone disease) Autoimmune diseases (m...

AbGenomics Corporation

Founded by a group of leading biomedical scientists in June 2000, AbGenomics Corporation is a biopharmaceutical company focusing on the discovery and development of novel therapeutic monoclonal antibodies for the treatment of 1). immune-related inflammatory diseases such as autoimmune diseases, allergy, asthma, and transplantation rejection; and 2). cancer. The Company's integrated bio-drug discov...

Pharma Focus Israel

Pharma Focus Israel is a premium International Research Management Organization providing product development services in the life science and health care industries. Founded in 1992 by prominent experts in all realms of clinical services, the mission of PFC Pharma Focus is to bring a new look to the drug development experience by addressing the limitations of conventional study methods. With 15 ...

Lumos Pharma, Inc.

Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and is funded by leading healthcare investors, including Deerfield, NEA, Clarus,...

Targacept

Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics (TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept’s product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system to promote therapeutic effects and limit adverse side effects. Targace...

AbGenomics US office

AbGenomics Corporation is a global biopharmaceutical company that endeavors to discover, develop and deliver therapeutic and diagnostic solutions in cancer and immune related diseases based on our proprietary technology platform. The Company's integrated bio-drug discovery capabilities range from the discovery of new gene function and the identification of disease target protein to the validati...

Ariad Pharmaceuticals Incorporated

ARIAD Pharmaceuticals, Inc. is focused on the discovery and development of novel and proprietary drugs based on its understanding of the inner-workings of cells and the genes involved in disease. The Company has developed a product based on its gene regulation technology to treat graft-versus-host disease, a complication of bone marrow transplantation involving an attack by a patient's immune syst...

C2N Diagnostics, LLC

C2N Diagnostics, LLC (www.c2ndiagnostics.com) formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, the Washington University Office of Technology Management, and LifeTech Research, a Maryland-based technology research and commercialization firm (www.lifetechresearch....

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen deficiency. This new class of drugs can be potentially developed in a broad range of clinical indications where therapeutic benefit can be obtained through an increased, regulated de...

The Partnership to Fight Chronic Disease New Jersey

The Partnership to Fight Chronic Disease (PFCD) is an internationally-recognized NGO of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs: chronic disease. For a collection of statistics and commentary o...

ConSynance Therapeutics, Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. The company’s pipeline includes innovative treatments for nonalcoholic steatohepatitis (NASH), the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. ConSynance are collaborating with Chengdu SciMount Pharmatech Co., Ltd., a drug discov...

Amarin Corporation plc

Amarin is a clinical-stage biopharmaceutical company with a focus on cardiovascular disease. The Company’s lead product candidate is AMR101(ethyl icosapentate), which is entering Phase 3 clinical trials for the treatment of very high triglycerides and high triglycerides in patients with mixed dyslipidemia, under Special Protocol Assessment agreements ...


More From BioPortfolio on "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks